Sysmex (OTCMKTS:SSMXY) Trading 1.3% Higher - Time to Buy?

Key Points

• Sysmex shares rose by 1.3% during trading, with a significant increase in trading volume of 435% compared to the average session volume.
• Goldman Sachs upgraded Sysmex from a "hold" to a "buy" rating, while the current analyst consensus is an average rating of "Moderate Buy".
• The company's latest earnings report showed a miss on earnings per share (EPS) estimates, with a reported EPS of $0.05 against an expected $0.12.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) shares traded up 1.3% during trading on Thursday . The stock traded as high as $11.89 and last traded at $11.85. 1,317,212 shares were traded during mid-day trading, an increase of 435% from the average session volume of 246,273 shares. The stock had previously closed at $11.70.

Wall Street Analyst Weigh In

Several analysts have commented on the company. The Goldman Sachs Group raised Sysmex from a "hold" rating to a "buy" rating in a report on Thursday, October 9th. Zacks Research raised Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy".

Sysmex Price Performance

The company has a debt-to-equity ratio of 0.12, a current ratio of 3.37 and a quick ratio of 2.49. The stock has a 50 day moving average price of $12.77 and a 200-day moving average price of $15.78. The stock has a market capitalization of $7.46 billion, a price-to-earnings ratio of 23.70 and a beta of 1.16.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The firm had revenue of $717.09 million during the quarter, compared to analyst estimates of $807.27 million. Sysmex had a return on equity of 10.20% and a net margin of 9.35%. On average, analysts forecast that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.